Pentraxin 3: A New Biomarker for Pediatric CNS Infections
Author Information
Author(s): El-Kady Huda, Mostafa Mona Gamal, Madkour Shaimaa
Primary Institution: Fayoum University, Fayoum, Egypt
Hypothesis
Can cerebrospinal fluid PTX3 levels serve as a diagnostic and prognostic biomarker in pediatric patients with CNS infections?
Conclusion
PTX3 levels can indicate disease severity and help differentiate between bacterial and aseptic CNS infections.
Supporting Evidence
- PTX3 levels were significantly correlated with the duration of symptoms and patient outcomes.
- Patients needing mechanical ventilation had higher PTX3 levels.
- PTX3 showed significant sensitivity in distinguishing bacterial from aseptic CNS infections.
Takeaway
This study found that a substance called PTX3 in the fluid around the brain can help doctors tell if kids have a serious brain infection caused by bacteria or a less serious one caused by a virus.
Methodology
A case-control study was conducted with 100 children suspected of CNS infections, measuring CSF PTX3 levels and correlating them with clinical outcomes.
Potential Biases
Potential bias due to the single-center design and reliance on specific diagnostic criteria.
Limitations
The study was limited to a single center, which may affect the generalizability of the results.
Participant Demographics
Children aged 1 month to 14 years with suspected CNS infections.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website